These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4302157)

  • 1. Live vaccines against influenza, adenoviruses, measles, and mumps.
    Smorodintsev AA; Alexandrova GI; Boychuck LM; Nasibov MN; Selivanov AA; Taros LY
    Arch Environ Health; 1969 Jan; 18(1):105-14. PubMed ID: 4302157
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA; Nasibov MN; Jakovleva NV
    Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 4. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined live measles, mumps, and rubella virus vaccines.
    Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
    [No Abstract]   [Full Text] [Related]  

  • 6. [Live vaccines against influenza and measles].
    Smorodintsev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):33-7. PubMed ID: 6485659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Theoretical and practical aspects of the problem of peroral immunization at the present time].
    Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):3-15. PubMed ID: 4367697
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].
    Zverev VV; Iuminova NV
    Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What is the present status of the common virus vaccines?].
    Regnard J
    Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188
    [No Abstract]   [Full Text] [Related]  

  • 14. Disease patterns and vaccine-response studies in isolated Micronesian populations.
    Brown P; Gajdusek DC
    Am J Trop Med Hyg; 1970 Jan; 19(1):170-5. PubMed ID: 4313560
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.
    Lum LC; Borja-Tabora CF; Breiman RF; Vesikari T; Sablan BP; Chay OM; Tantracheewathorn T; Schmitt HJ; Lau YL; Bowonkiratikachorn P; Tam JS; Lee BW; Tan KK; Pejcz J; Cha S; Gutierrez-Brito M; Kaltenis P; Vertruyen A; Czajka H; Bojarskas J; Brooks WA; Cheng SM; Rappaport R; Baker S; Gruber WC; Forrest BD
    Vaccine; 2010 Feb; 28(6):1566-74. PubMed ID: 20003918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term epidemiologic longitudinal study on the effect of vaccines on public inoculation.
    Matsuoka I; Matsuoka T; Matsuoka A; Shigemura T; Agematsu K; Koike K
    Turk J Pediatr; 2012; 54(4):376-81. PubMed ID: 23692718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 18. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemic problems of measles and mumps inoculation].
    Allerdist H
    Offentl Gesundheitswes; 1979 Sep; 41 Suppl 1():51-6. PubMed ID: 161394
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune responses of mentally retarded subjects to measles, mumps and rubella vaccines.
    Sinha SK; Carlson SD
    Wis Med J; 1975 Jul; 74(7):75-7. PubMed ID: 1163054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.